DEF 14A: Perma-Pipe Seeks Stockholder Approval for 2024 Omnibus Incentive Plan and Director Elections

Sentiment:

Proxy Statement


Perma-Pipe International Holdings is soliciting proxies for its 2024 annual meeting, covering director elections, executive compensation, ratification of accountants, and approval of a new stock incentive plan.

Summary

  • Perma-Pipe International Holdings, Inc. is holding its 2024 Annual Meeting of Stockholders on July 25, 2024, virtually.
  • Stockholders will vote on electing five directors, approving executive compensation on an advisory basis, ratifying the appointment of PricewaterhouseCoopers LLP as the independent accountant for the fiscal year ending January 31, 2025, and approving the 2024 Omnibus Plan through 2027.
  • The Board recommends voting FOR all proposals.
  • The company is requesting approval for the 2024 Omnibus Stock Incentive Plan, which includes the authority to issue up to 530,000 shares of Common Stock.
  • The 2024 Plan is intended to replace the 2021 OMNIBUS STOCK INCENTIVE PLAN, which expires in May 2024.
  • The company's executive compensation program is designed to link executives' pay to individual and company performance, with a focus on long-term growth and stockholder value.
  • The company's Board consists of five directors, four of whom are independent.
  • The company has adopted a retirement policy requiring non-employee directors to retire from the Board on the date of the Annual Meeting following their 72nd birthday.
  • The company's Board has implemented stock ownership guidelines for executives and directors to align their interests with those of stockholders.
  • The company has adopted a clawback policy for recouping executive compensation in certain events.
  • The company's Audit Committee has appointed PricewaterhouseCoopers LLP as the company's independent accountant for the fiscal year ending January 31, 2025.
  • The company is committed to ethical governance, diversity, equity, and inclusion, safety, and sustainability.
  • The company's operations take into account governance, social and environmental factors.

Sentiment

Score: 7

Explanation: The document presents a balanced view, highlighting both achievements and ongoing efforts to improve governance and performance. The tone is professional and forward-looking, suggesting a positive outlook.

Positives

  • The company is implementing strong corporate governance practices, including a retirement policy for directors, stock ownership guidelines for executives and directors, and a clawback policy for recouping executive compensation.
  • The company is committed to diversity, equity, and inclusion, safety, and sustainability.
  • The company is seeking stockholder approval for a new omnibus stock incentive plan to attract, retain, and reward key personnel.
  • The company's Board consists of a majority of independent directors.
  • The company is transitioning to a larger global accounting firm with a strong international presence.

Risks

  • Failure to obtain stockholder approval for the 2024 Omnibus Plan would prevent the company from granting equity awards to employees, officers, and directors.
  • The company's performance-based compensation plans rely on achieving specific financial targets, which may not be met.
  • The company's executive compensation program may not be effective in attracting, motivating, and retaining highly talented individuals.
  • The company's operations are subject to various risks, including financial, nonfinancial, and cybersecurity risks.

Future Outlook

The company anticipates that the 2024 Plan provides for a sufficient number of shares of stock to meet our equity grant needs for approximately 3 years, based on our historic grant rates and the approximate stock price, but the shares may be depleted faster or slower than that if actual issuance does not match projected rates or our stock price changes materially.

Management Comments

  • We continue to commit ourselves to relentlessly focusing on our strategies to improve business performance and drive profitable growth.
  • Our relentless focus on growth and business improvement is providing demonstrable results as evidenced by our recently announced FY2023 financials.
  • We regularly review and update our Boards structure, policies, committee charters, and practices based upon input from investors and third-party experts in corporate governance as well as comparison to the practices of other public companies.

Industry Context

The company operates in the industrial manufacturing sector and competes for talent with other companies in this sector. The company's compensation practices are benchmarked against a group of peer companies in the manufacturing industry.

Comparison to Industry Standards

  • The WTW benchmark assessment of executive compensation compared the design and compensation levels of our current executive compensation program to a market benchmarking reference group of general industry companies which have revenues similar to the Company.
  • The benchmark study concluded that our executive total direct compensation was 21% below the 50th percentile of the market study.
  • Our Custom Peer Group is made up of 15 public companies including Ampco-Pittsburgh Corporation, Manitex International, Inc., and Broadwind, Inc.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerBryan NorwoodMatthew LewickiOctober 2, 2023Bryan Norwood announced his retirement

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Retirement PolicyBoard adopted a retirement policy requiring non-employee directors to retire from the Board, and not stand for re-election, on the date of the Annual Meeting following their 72nd birthday.N/AEnsures board refreshment and brings in new perspectives.
Stockholder Right to Call Special MeetingsBoard revised Bylaws to permit stockholders holding 10% of our outstanding common stock to call a special meeting without limitation.April 30, 2019Empowers stockholders and increases accountability.
Poison Pill EliminationStockholder Rights Plan, or Poison Pill, was intentionally allowed to expire and has not been extended or renewed.September 15, 2019Removes potential barrier to takeover and increases stockholder value.
Clawback PolicyThe Board has updated our Compensation Committee Charter and Clawback Policy to meet SEC and NASDAQ requirements for our policies relating to clawbacks for incentive compensation paid to executive officers.N/AAllows the company to recoup compensation from executives in certain circumstances.

Related Party Transactions

  • There were no related party transactions in 2023.

Stakeholder Impact

  • The company's actions and decisions impact key stakeholders such as shareholders, employees, customers, suppliers, and creditors.
  • The company strives for ESG excellence every day.
  • The Company's stakeholders, which include its workers, customers, vendors, business partners, shareholders and communities all around the world, look to our principles to consistently display integrity, respect, and sound business judgment when it comes to matters of the environment, social equality and corporate governance.

Next Steps

  • Stockholders are urged to vote on the proposals outlined in the proxy statement.
  • The company will hold its 2024 Annual Meeting of Stockholders on July 25, 2024.
  • The company will continue to review and update its corporate governance practices and executive compensation program.

Key Dates

DateDescription
2014Jerome T. Walker has been a director of the Company since 2014.
2015David B. Brown has been a director of the Company since 2015.
November 2016David J. Mansfield has been the Company's President and Chief Executive Officer since November 2016.
January 30, 2017David J. Mansfield has been a director of the Company since January 30, 2017.
2019Cynthia A. Boiter has been a director of the Company since 2019.
April 30, 2019On April 30, 2019, our Board revised our Bylaws to permit stockholders holding 10% of our outstanding common stock to call a special meeting without limitation.
September 15, 2019Our Stockholder Rights Plan, or Poison Pill, was intentionally allowed to expire on September 15, 2019 and has not been extended or renewed.
June 2020The Board updated it s Nominating and Corporate Governance Committee Charter in June 2020.
October 2021The Board last updated i ts Audit Committee Charter in October 2021.
June 10, 2021Mr.Sagr joined the Company on June 10, 2021, and was appointed Senior Vice President MENA.
July 26, 2021Mr. Dewbre was appointed Chief Operating Officer on July 26, 2021.
February 2022Robert J. McNally joined the Company's Board as an independent director in February 2022.
June 2022Jerome T. Walker has served as independent Chairman of the Board since June 2022.
May 2, 2023Mr. Lewicki joined the Company on May 2, 2023 as Chief Accounting Officer.
June 22, 2023The Companys stockholders ratified the engagement of Grant Thornton LLP at the 2023 annual meeting of stockholders on June 22, 2023.
July 4, 2023Grant W. Dewbre, the Companys Chief Operating Officer, who resigned on July 4, 2023 from his position.
October 2, 2023Mr. Lewicki was appointed Vice President and Chief Financial Officer on October 2, 2023.
December 31, 2023Mr. Norwood retired from the Company on December 31, 2023, after giving the required notice.
January 2024The Company updated the Code of Conduct in January 2024.
February 9, 2024According to a Schedule 13G filed February 9, 2024, Dimensional Fund Advisors LP ('DFA'), in its capacity as investment adviser, may be deemed the beneficial owner of 444,985 shares of Common Stock as of December 29, 2023.
May 28, 2024On May 28, 2024, upon the recommendation of the Compensation Committee, the Board unanimously approved the 2024 Plan, subject to stockholder approval, and directed that it be sent for the approval of the stockholders.
June 12, 2024Stockholders of record at the close of business on June 12, 2024 are entitled to notice of and to vote prior to the date of the meeting.
June 21, 2024June 21, 2024 Dear Fellow Stockholders:
July 25, 2024Thursday, July 25, 2024 1:00 p.m. Central Time Online at www.virtualshareholdermeeting.com/PPIH2024
January 9, 2025In order to be eligible for inclusion in the Proxy Statement and Proxy Form relating to such meeting pursuant to the rules and regulations of the SEC, any proposal which a stockholder intends to present at the Companys 2025 Annual Meeting of Stockholders must be in writing, must be received by the Company at its principal executive offices in Spring, Texas by January 9, 2025 and must satisfy the applicable rules and regulations of the SEC.
February 23, 2024For the 2024 annual meeting of stockholders, a proposal or recommendation for nomination must be received by the Board not earlier than February 23, 2024 and not later than March 24, 2024.
March 24, 2024For the 2024 annual meeting of stockholders, a proposal or recommendation for nomination must be received by the Board not earlier than February 23, 2024 and not later than March 24, 2024.

Keywords

proxy statement, annual meeting, directors, executive compensation, stock incentive plan, corporate governance, PricewaterhouseCoopers, audit committee, stockholders, Perma-Pipe

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.